1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Respiratory Tract Infection Therapeutic Market, by Drugs
6.1. Introduction
6.2. Antibiotics
6.3. Cough Suppressants
6.4. Nasal Decongestants
6.5. Non-steroidal Anti-inflammatory Drugs

7. Respiratory Tract Infection Therapeutic Market, by Disease Indication
7.1. Introduction
7.2. Lower Respiratory Tract Infection
7.3. Upper Respiratory Tract Infection

8. Respiratory Tract Infection Therapeutic Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies

9. California Respiratory Tract Infection Therapeutic Market

10. Florida Respiratory Tract Infection Therapeutic Market

11. Illinois Respiratory Tract Infection Therapeutic Market

12. New York Respiratory Tract Infection Therapeutic Market

13. Ohio Respiratory Tract Infection Therapeutic Market

14. Pennsylvania Respiratory Tract Infection Therapeutic Market

15. Texas Respiratory Tract Infection Therapeutic Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Abbott
17.2. AbbVie Inc.
17.3. Allergan
17.4. Apotex Corporation
17.5. Ascend Laboratories Ltd
17.6. AstraZeneca
17.7. Auro Pharma Inc
17.8. Aurobindo Pharma
17.9. AuroMedics Pharma LLC
17.10. Bristol-Myers Squibb Company
17.11. Cardinal Health
17.12. Claris Lifesciences, Inc.
17.13. F. Hoffmann-La Roche Ltd
17.14. Fresenius Kabi USA, LLC
17.15. GlaxoSmithKline plc
17.16. Hikma Pharmaceuticals USA Inc.
17.17. Hospira, Inc.
17.18. Laboratorios Quimica Son's, S.A. de C.V
17.19. Merck & Co., Inc.
17.20. Novartis AG
17.21. Pfizer Inc.
17.22. Physicians Total Care, Inc.
17.23. Piramal Critical Care Inc
17.24. Pragma Pharmaceuticals, LLC
17.25. Sandoz Inc
17.26. Teva Pharmaceutical Industries Ltd.
17.27. WG Critical Care, LLC

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY DRUGS, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY DRUGS, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY DRUGS, 2027
FIGURE 6. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY ANTIBIOTICS, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY ANTIBIOTICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY COUGH SUPPRESSANTS, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY COUGH SUPPRESSANTS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY NASAL DECONGESTANTS, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY NASAL DECONGESTANTS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 14. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY DISEASE INDICATION, 2020 VS 2027 (%)
FIGURE 15. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY DISEASE INDICATION, 2020 VS 2027 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY DISEASE INDICATION, 2027
FIGURE 17. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY LOWER RESPIRATORY TRACT INFECTION, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY LOWER RESPIRATORY TRACT INFECTION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2027 (%)
FIGURE 22. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2027 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 24. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 25. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 26. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY ONLINE PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 27. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 28. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY RETAIL PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 29. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 30. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET: FPNV POSITIONING MATRIX
FIGURE 31. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 32. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY ANTIBIOTICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY COUGH SUPPRESSANTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY NASAL DECONGESTANTS, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY LOWER RESPIRATORY TRACT INFECTION, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET: SCORES
TABLE 16. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET: BUSINESS STRATEGY
TABLE 17. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET: PRODUCT SATISFACTION
TABLE 18. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET: RANKING
TABLE 19. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 20. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET: MERGER & ACQUISITION
TABLE 21. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 22. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 23. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET: INVESTMENT & FUNDING
TABLE 24. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 25. UNITED STATES RESPIRATORY TRACT INFECTION THERAPEUTIC MARKET: LICENSE & PRICING

Companies Mentioned

Abbott
AbbVie Inc.
Allergan
Apotex Corporation
Ascend Laboratories Ltd
AstraZeneca
Auro Pharma Inc
Aurobindo Pharma
AuroMedics Pharma LLC
Bristol-Myers Squibb Company
Cardinal Health
Claris Lifesciences, Inc.
F. Hoffmann-La Roche Ltd
Fresenius Kabi USA, LLC
GlaxoSmithKline plc
Hikma Pharmaceuticals USA Inc.
Hospira, Inc.
Laboratorios Quimica Son's, S.A. de C.V
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Physicians Total Care, Inc.
Piramal Critical Care Inc
Pragma Pharmaceuticals, LLC
Sandoz Inc
Teva Pharmaceutical Industries Ltd.
WG Critical Care, LLC